No description available.

The FeMo cofactor is one of two types of prosthetic group found in the larger of the two nitrogenase component proteins, called the MoFe protein, and it is strongly implicated as the substrate binding and reduction site. The glutamine-191 residue in the Alpha-subunit of the MoFe protein of A. vinelandii nitrogenase was targeted for substitution because its side chain is involved in a hydrogen-bond network from one of the terminal carboxylates of the homocitrate component of FeMo cofactor through to the backbone NH of Alpha Gly-61, which is adjacent to Alpha Cys-62, which ligates to the P cluster (the second type of prosthetic group in the MoFe protein). A variety of altered MoFe proteins produced by the A. vinelandii mutant strains, namely the Alpha Pro-191, Alpha Ser-191, Alpha Thr-191, Alpha His-191, Alpha Glu-191, and Alpha Arg-191 altered MoFe proteins, have been purified to homogeneity and the catalytic properties of these altered MoFe proteins have been compared to those of wild type MoFe protein. Unlike wild type, the six altered MoFe proteins have decreased catalytic activity on substrate reduction and exhibited H2 evolution that was partially inhibited by added CO. Moreover, some of altered MoFe proteins with lower specific activity for the C2H4 production can produce C2H6 from C2H2. The results from the pH and activity studies indicate that the substitutions on the MoFe protein have an effect on the contribution of the responsible acid-base group(s) involved in proton transfer for H+- and C2H2-reduction. Furthermore, the inhibition by CO of hydrogen evolution by these altered MoFe proteins is likely from a lowering of the rate of both electron and proton transfer to the H+- reduction site(s). Some altered MoFe proteins but not wild type MoFe protein can produce C2H6 from C2H2. This observation suggested a lower apparent binding affinity for C2H2 and a slower proton transfer to C2H2 reduction with these altered MoFe proteins, which allow the intermediate to stay at the site longer and be further reduced by two electrons and two protons to give C2H6. These changes in the biochemical properties of these altered MoFe proteins indicate that the Alpha Gln-191 residue is intimately involved in substrate binding and reduction including proton delivery to substrate. / Ph. D.

Blast-induced traumatic brain injury (bTBI) remains a significant problem among military populations. When an explosion occurs, a high magnitude positive pressure rapidly propagates away from the detonation source. Upon contact, biological tissues throughout the body undergo deformation at high strain rates and then return to equilibrium following a brief negative pressure phase. This mechanical disruption of the tissue is known to cause oxidative stress and neuroinflammation in the brain, which can lead to neurodegeneration and consequently poor cognitive and behavioral outcomes. Further, these clinical outcomes, which can include chronic headaches, problems with balance, light and noise sensitivity, anxiety, and depression, may be sustained years following blast exposure and there are currently no effective treatments. Thus, there is a need to investigate the acute molecular responses following bTBI in order to motivate the development of effective therapeutic strategies and ultimately improve or prevent long-term patient outcomes. It is important to not only understand the acute molecular response, but how the brain tissue mechanics drive these metabolic changes. The objective of this work was to identify the interplay between the tissue-level biomechanics and the acute bTBI pathophysiology. In a rodent bTBI model, using adult rats, intracranial pressure was mapped throughout the brain during blast exposure where frequency contributions from skull flexure and wave dynamics were significantly altered between brain regions and were largely dependent on blast magnitude. These findings informed the subsequent spatial and temporal changes in neurometabolism. Amino acid molecular precursor concentrations decreased at four hours post-blast in the cortex and hippocampus regions. This motivates further investigation of amino acids as therapeutic targets aimed to reduce oxidative stress and prevent prolonged injury cascades. However, neurochemical changes were not consistent across blast magnitudes, which may be explained by the disparities in biomechanics at lower blast pressures. Lastly, we investigated the acute changes in metabolic regulators influencing excitotoxicity where it was found that astrocytes maintained normal clearance of excitatory and inhibitory neurotransmitters prior to astrocyte reactivity. Outcomes of this work provide improved understanding of blast mechanics and associated acute pathophysiology and inform future therapeutic and diagnostic approaches following bTBI. / Doctor of Philosophy / Blast-induced traumatic brain injury (bTBI) remains a significant problem among military populations. When an explosion occurs, a high magnitude positive pressure wave rapidly propagates away from the detonation source. Upon contact, biological tissues throughout the body undergo deformation that can cause injury. This mechanical disruption of the tissue is known to trigger negative biological processes that lead to persistent cognitive and behavioral deficits. Further, these clinical outcomes, which can include chronic headaches, problems with balance, light and noise sensitivity, anxiety, and depression, may be sustained years following blast exposure. There are currently no effective treatments that can help those afflicted, and biomarkers for injury diagnostics are limited. Thus, there is a great need to investigate the early biological responses following bTBI in order to motivate the development of effective therapeutic strategies and ultimately improve or prevent long-term patient outcomes. It is important to not only understand the immediate responses, but also how the brain tissue mechanics drive these metabolic changes. The objective of this work was to identify the interplay between the brain biomechanics and the acute bTBI pathophysiology. Using a translational animal model, pressure inside the brain was measured with pressure sensors during blast exposure. Subsequent spatial and temporal changes in neurochemical concentrations were quantified. The results showed (1) significant disparities in the pressure dynamics inside the brain and it varied across brain regions, (2) neurochemical precursors may have therapeutic potential post-injury, and (3) biomechanical and neurochemical responses were dependent on blast severity. Outcomes of this work provide improved understanding of blast mechanics and associated pathophysiology and inform future therapeutic and diagnostic approaches to prevent prolonged injury cascades.

Deuteration is the replacement of a hydrogen atom by deuterium atom in a molecule. The replacement begins at the most acidic hydrogen in the molecule. In ATP, the deshielded hydrogen is C8-H which is the first replaced during deuteration. During ATP deuteration some of the ATP is hydrolysed to ADP concurrently. Using kinetic analysis, it was confirmed that the ATP hydrolysis that occurs is 1st order in ATP concentration, while the hydrogen replacement is 2nd order. The ATP and its C8 deuterated analogue were tested against three enzymes shikimate kinase (SK), acetate kinase (AK) and glutamine synthetase (GS) to determine if a kinetic isotope effect (KIE) exists in these systems. With AK and GS, the KIED increased as the KIEH decreased, while with SK the KIED decreased as the KIEH increased as the concentration of the ATP or deuterated analogue increased. Deuteration of imidazole and purine compounds reduced the specific activity of AK or SK at low concentrations in an enzyme-catalysed reaction. From a library of imidazole-containing compounds that inhibited SK, three compounds were selected and their IC50 values were determined on the SK-catalysed reaction. These compounds show a differential potency and efficiency between their protonated and deuterated analogues when compared in a 1:1 mixture. Synthesized purines incorporating three different substituents at N-9 were tested against AK or SK for their ability to lower the specific activity of the enzymes used / Physics / M. Sc. (Physics)

Les neutrophiles sont généralement considérés résistants aux glucocorticoïdes. Cependant, peu d’études comparant l’effet de ces drogues sur les neutrophiles et les autres leucocytes sanguins (monocytes, lymphocytes et éosinophiles) ont été rapportées. Dans notre étude, nous avons évalué la réponse aux glucocorticoïdes de ces deux populations cellulaires chez le cheval et l’homme. Les cellules, préalablement isolées du sang de 6 chevaux et 4 sujets humains sains, ont été incubées pendant 5 h en présence de lipopolysaccharide (LPS; 100 ng/mL) seul ou combiné avec de l’hydrocortisone, de la prednisolone ou de la dexaméthasone (10-8M et 10-6M). L’expression d’ARNm pour l’IL-1β, le TNF-α, l’IL-8, la glutamine synthétase et le récepteur α des glucocorticoïdes (GR-α) a été quantifiée par qPCR. Les neutrophiles équins ont également été incubés pendant 20 h en présence de ces 3 glucocorticoïdes et la survie cellulaire a été évaluée par cytométrie de flux et microscopie optique. Nous avons démontré que les glucocorticoïdes inhibaient l’expression des gènes pro-inflammatoires induite par le LPS pour les deux populations cellulaires chez les deux espèces étudiées. L’expression de la glutamine synthétase était également significativement augmentée par les glucocorticoïdes chez les neutrophiles et les autres leucocytes sanguins équins. De manière générale, l’intensité de la réponse aux glucocorticoïdes s’est avérée similaire dans les 2 populations leucocytaires et chez les deux espèces. Les glucocorticoïdes augmentaient également la survie des neutrophiles équins, phénomène également rapporté dans d’autres espèces. Ainsi, les glucococorticoïdes exercent des effets d’intensité comparable sur les neutrophiles et les autres leucocytes sanguins. Nous spéculons que la faible réponse à la corticothérapie observée lors de maladies inflammatoires chroniques neutrophiliques comme l’asthme sévère ou la Maladie Pulmonaire Obstructive Chronique (MPOC) ne s’explique pas par une corticorésistance intrinsèque des neutrophiles. / Neutrophils are generally considered resistant to glucocorticoids compared to other inflammatory cells. However, there are few studies comparing the effects of glucocorticoids in neutrophils and those of other blood leukocytes (monocytes, lymphocytes and eosinophils). In our study, we assessed glucocorticoid-responsiveness in equine and human peripheral blood neutrophils and in neutrophil-depleted leukocytes. Cells were isolated from 6 healthy horses and 4 human healthy subjects. They were incubated for 5 h with or without lipopolysaccharide (LPS; 100 ng/mL) alone or combined with hydrocortisone, prednisolone or dexamethasone (10-8M and 10-6M). IL-1β, TNF-α, IL-8, glutamine synthetase and Glucocorticoid Receptor α (GR-α) mRNA expression was quantified by qPCR. Equine neutrophils were also incubated for 20 h with or without the three glucocorticoids and cell survival was assessed by flow cytometry and light microscopy. We found that glucocorticoids down-regulated LPS-induced pro-inflammatory mRNA expression in both cell populations and species. These drugs also significantly increased glutamine synthetase gene expression in both equine cell populations. The magnitude of glucocorticoid response was generally similar in both cell populations and species. As reported in other species, glucocorticoids significantly increase the survival in equine neutrophils. Based on these results, it appears that glucocorticoids exert effects of similar magnitude on neutrophils and on other blood leukocytes. We speculate that the poor response to glucocorticoids observed in some chronic neutrophilic human diseases such as severe asthma or Chronic Obstructive Pulmonary Disease (COPD) is not explained by an inherent attenuated response of neutrophils to these drugs.

Les neutrophiles sont généralement considérés résistants aux glucocorticoïdes. Cependant, peu d’études comparant l’effet de ces drogues sur les neutrophiles et les autres leucocytes sanguins (monocytes, lymphocytes et éosinophiles) ont été rapportées. Dans notre étude, nous avons évalué la réponse aux glucocorticoïdes de ces deux populations cellulaires chez le cheval et l’homme. Les cellules, préalablement isolées du sang de 6 chevaux et 4 sujets humains sains, ont été incubées pendant 5 h en présence de lipopolysaccharide (LPS; 100 ng/mL) seul ou combiné avec de l’hydrocortisone, de la prednisolone ou de la dexaméthasone (10-8M et 10-6M). L’expression d’ARNm pour l’IL-1β, le TNF-α, l’IL-8, la glutamine synthétase et le récepteur α des glucocorticoïdes (GR-α) a été quantifiée par qPCR. Les neutrophiles équins ont également été incubés pendant 20 h en présence de ces 3 glucocorticoïdes et la survie cellulaire a été évaluée par cytométrie de flux et microscopie optique. Nous avons démontré que les glucocorticoïdes inhibaient l’expression des gènes pro-inflammatoires induite par le LPS pour les deux populations cellulaires chez les deux espèces étudiées. L’expression de la glutamine synthétase était également significativement augmentée par les glucocorticoïdes chez les neutrophiles et les autres leucocytes sanguins équins. De manière générale, l’intensité de la réponse aux glucocorticoïdes s’est avérée similaire dans les 2 populations leucocytaires et chez les deux espèces. Les glucocorticoïdes augmentaient également la survie des neutrophiles équins, phénomène également rapporté dans d’autres espèces. Ainsi, les glucococorticoïdes exercent des effets d’intensité comparable sur les neutrophiles et les autres leucocytes sanguins. Nous spéculons que la faible réponse à la corticothérapie observée lors de maladies inflammatoires chroniques neutrophiliques comme l’asthme sévère ou la Maladie Pulmonaire Obstructive Chronique (MPOC) ne s’explique pas par une corticorésistance intrinsèque des neutrophiles. / Neutrophils are generally considered resistant to glucocorticoids compared to other inflammatory cells. However, there are few studies comparing the effects of glucocorticoids in neutrophils and those of other blood leukocytes (monocytes, lymphocytes and eosinophils). In our study, we assessed glucocorticoid-responsiveness in equine and human peripheral blood neutrophils and in neutrophil-depleted leukocytes. Cells were isolated from 6 healthy horses and 4 human healthy subjects. They were incubated for 5 h with or without lipopolysaccharide (LPS; 100 ng/mL) alone or combined with hydrocortisone, prednisolone or dexamethasone (10-8M and 10-6M). IL-1β, TNF-α, IL-8, glutamine synthetase and Glucocorticoid Receptor α (GR-α) mRNA expression was quantified by qPCR. Equine neutrophils were also incubated for 20 h with or without the three glucocorticoids and cell survival was assessed by flow cytometry and light microscopy. We found that glucocorticoids down-regulated LPS-induced pro-inflammatory mRNA expression in both cell populations and species. These drugs also significantly increased glutamine synthetase gene expression in both equine cell populations. The magnitude of glucocorticoid response was generally similar in both cell populations and species. As reported in other species, glucocorticoids significantly increase the survival in equine neutrophils. Based on these results, it appears that glucocorticoids exert effects of similar magnitude on neutrophils and on other blood leukocytes. We speculate that the poor response to glucocorticoids observed in some chronic neutrophilic human diseases such as severe asthma or Chronic Obstructive Pulmonary Disease (COPD) is not explained by an inherent attenuated response of neutrophils to these drugs.

Deuteration is the replacement of a hydrogen atom by deuterium atom in a molecule. The replacement begins at the most acidic hydrogen in the molecule. In ATP, the deshielded hydrogen is C8-H which is the first replaced during deuteration. During ATP deuteration some of the ATP is hydrolysed to ADP concurrently. Using kinetic analysis, it was confirmed that the ATP hydrolysis that occurs is 1st order in ATP concentration, while the hydrogen replacement is 2nd order. The ATP and its C8 deuterated analogue were tested against three enzymes shikimate kinase (SK), acetate kinase (AK) and glutamine synthetase (GS) to determine if a kinetic isotope effect (KIE) exists in these systems. With AK and GS, the KIED increased as the KIEH decreased, while with SK the KIED decreased as the KIEH increased as the concentration of the ATP or deuterated analogue increased. Deuteration of imidazole and purine compounds reduced the specific activity of AK or SK at low concentrations in an enzyme-catalysed reaction. From a library of imidazole-containing compounds that inhibited SK, three compounds were selected and their IC50 values were determined on the SK-catalysed reaction. These compounds show a differential potency and efficiency between their protonated and deuterated analogues when compared in a 1:1 mixture. Synthesized purines incorporating three different substituents at N-9 were tested against AK or SK for their ability to lower the specific activity of the enzymes used / Physics / M. Sc. (Physics)

Contexte et objectifs : L'encéphalopathie hépatique (EH) est un trouble neuropsychiatrique, une complication majeure de la maladie hépatique chronique (MHC). L'EH se manifeste par un large éventail de symptômes, allant d'un léger manque d'attention et de troubles de la mémoire à une léthargie sévère et un coma. L'hyperammoniémie est centrale dans la pathogenèse de l'EH puisque l'ammoniac est neurotoxique et que l'ammoniac dérivé du sang traverse facilement la barrière hémato-encéphalique (BHE). Cependant, d'autres facteurs pathogènes sont également impliqués dans l'EH, notamment le stress oxydatif. Au cours de la MHC, le muscle joue un rôle compensatoire essentiel dans l'élimination de l'ammoniac par l'action de l'enzyme glutamine synthétase (GS), qui transforme le glutamate en glutamine. Étant donné que les cellules endothéliales de la BHE sont l'interface entre le sang et le cerveau, il est plausible qu'elles métabolisent l'ammoniac pour protéger le cerveau de la neurotoxicité induite par l'ammoniac. Cependant, cela n'a jamais fait l'objet d'études. Les thérapies de réduction de l'ammoniac sont les traitements courants de l'EH. Cependant, les réponses des patients aux traitements sont hétérogènes, et les différences de sexe pourraient en être la cause. Par conséquent, nos objectifs étaient 1) d'explorer le métabolisme de l'ammoniac dans les cellules endothéliales de la BHE par la présence de GS et 2) d'évaluer l'impact du sexe sur la MHC et ses complications, y compris la sarcopénie et l'EH. Méthodes : Pour le premier objectif, nous avons évalué l'expression et l'activité de la protéine GS in vitro et ex vivo chez des rats naïfs. Nous avons également évalué l'impact de l'ornithine, du glutamate et du α-kétoglutarate sur l'activité de la GS dans les cellules endothéliales de la BHE via la génération de glutamine 5-13C marquée. Pour le deuxième objectif, nous avons évalué l'impact du sexe sur le neurophénotype (anxiété, mémoire, coordination motrice et activité) chez des rats ligaturés des voies biliaires (BDL) (et contrôles respectifs) ainsi que sur le développement d'une EH sévère (léthargie/perte du réflexe de redressement). Nous avons également évalué les marqueurs des lésions hépatiques, l'hyperammoniémie, le stress oxydatif systémique, la masse et la fonction musculaire et la clairance de l'ammoniac musculaire. Résultats : Nous avons trouvé l'activité et l'expression de la GS in vivo et ex vivo dans les cellules endothéliales de la BHE. L'analyse au microscope confocal a montré que la GS dans les cellules endothéliales est moins abondante que dans les astrocytes. L'exposition de cellules endothéliales cultivées à des substrats marqués a révélé que l'ornithine est la plus efficace pour générer de la glutamine. Chez les femmes, la chirurgie BDL a provoqué une MHC (augmentation des enzymes hépatiques circulantes et de la bilirubine) et de l'EH (altération de la coordination motrice et de l'activité nocturne) par rapport aux rats contrôles respectifs. De plus, le degré d'hyperammoniémie et la clairance musculaire de l'ammoniac étaient similaires entre les sexes. Contrairement aux mâles, les rats femelles n'ont pas développé de perte musculaire, d'œdème cérébral et de perte de mémoire à court terme. De plus, les femelles présentaient un stress oxydatif plus faible et étaient complètement protégées contre les EH sévères précipitées par l'ammoniac par rapport aux mâles BDL. Conclusions : Nous concluons que la GS est exprimée dans les cellules endothéliales de la BHE, jouant peut-être un rôle dans l'atténuation ou le retard de l'entrée de l'ammoniac dans le cerveau et que la supplémentation en ornithine améliore l'activité de la GS en fournissant du glutamate pour la détoxification de l'ammoniac. De plus, nous concluons que le sexe a un impact sur les complications des maladies du foie, y compris la sarcopénie et l'EH, le stress oxydatif systémique jouant un rôle vital dans la susceptibilité à l'EH sévère induite par l'ammoniac. / Background and aims: Hepatic encephalopathy (HE) is a neuropsychiatric disorder and a major complication of chronic liver disease (CLD). HE manifests with a wide range of symptoms, from mild lack of attention and memory impairments to severe lethargy and coma. Hyperammonemia is central in the pathogenesis of HE since ammonia is neurotoxic, and blood-derived ammonia easily crosses the blood-brain barrier (BBB). However, other pathogenic factors are also implicated in HE, including oxidative stress. During CLD, muscle plays an essential compensatory role in removing ammonia by the action of the enzyme glutamine synthetase (GS), which amidates glutamate into glutamine. Since the endothelial cells of the BBB are the interface between the blood and the brain, it is plausible that they metabolize ammonia to protect the brain from ammonia-induced neurotoxicity. However, this has never been investigated. Ammonia lowering therapies are the mainstream treatments for HE. However, patients' response to treatments are heterogeneous, and sex differences might be the cause. Therefore, our aims were 1) To explore ammonia metabolism in BBB’s endothelial cells through the presence of GS and 2) to assess the impact of sex on CLD and its complications, including sarcopenia and HE. Methods: For the first aim, we assessed GS protein expression and activity in vitro and ex vivo in naïve rats. We also evaluated the impact of ornithine, glutamate, and α-ketoglutarate on GS activity in endothelial cells of the BBB via the generation of labeled 5-13C glutamine. For the second aim, we assessed the impact of sex on the neurophenotype (anxiety, memory, motor coordination, and activity) in bile-duct ligated (BDL) rats (and respective SHAMs) as well as on the development of an ammonia-precipitated severe HE (lethargy/loss of righting reflex). We also assessed liver injury markers, hyperammonemia, systemic oxidative stress, muscle mass and function, and muscle ammonia clearance. Results: We found GS activity and expression in vivo and ex vivo in endothelial BBB cells. The confocal microscope analysis showed that GS in endothelial cells is less abundant than astrocytes. Exposing cultured endothelial cells to labeled substrates revealed that ornithine is the most efficient in generating glutamine. In females, BDL surgery caused CLD (increased hepatic enzymes and bilirubin) and HE (impaired motor coordination and night activity) vs. respective SHAMs. Furthermore, the degree of hyperammonemia and muscle ammonia clearance was similar between sexes. Contrary to males, female rats did not develop muscle loss, brain edema, and short-term memory loss. In addition, females had lower oxidative stress and were completely protected against ammonia-precipitated severe HE compared to male BDLs. Conclusions: We conclude that GS is expressed in endothelial cells of the BBB, possibly playing a role in attenuating or delaying ammonia entry into the brain and, ornithine supplementation enhances GS activity by providing glutamate for ammonia detoxification. In addition, we conclude that sex impacts the complications of liver disease, including sarcopenia and HE, with systemic oxidative stress playing a vital role in the susceptibility to ammonia-induced overt HE.

<p>During brain activity neurons release the major excitatory transmitter glutamate, which is taken up by astrocytes and converted to glutamine. Glutamine returns to neurons for re-conversion to glutamate. This glutamate-glutamine cycle is energy demanding. Glutamate turnover in injured brain was studied using an animal iron-induced posttraumatic epilepsy model and using neurointensive care data from 33 patients with spontaneous subarachnoid hemorrhage (SAH). Immunoblotting revealed that the functional form of the major astrocytic glutamate uptake protein GLT-1 was decreased 1-5 days following a cortical epileptogenic iron-injection, presumably due to oxidation-induced aggregation. Using microdialysis it was shown that the GLT-1 decrease was associated with increased interstitial glutamate levels and decreased interstitial glutamine levels. The results indicate a possible posttraumatic and post-stroke epileptogenic mechanism. Analysing 3600 microdialysis hours from patients it was found that the interstitial lactate/pyruvate (L/P) ratio correlate with the glutamine/glutamate ratio (r =-0.66). This correlation was as strong as the correlation between L/P and glutamate (r=0.68) and between lactate and glutamate (r=0.65). Pyruvate and glutamine correlated linearly (r=0.52). Energy failure periods, defined as L/P>40, were associated with high interstitial glutamate levels. Glutamine increased or decreased during energy failure periods depending on pyruvate. Energy failure periods were clinically associated with delayed ischemic neurological deficits (DIND) or development of radiologically verified infarcts, confirming that L/P>40 is a pathological microdialysis pattern that can predict ischemic deterioration after SAH. DIND-associated microdialysis patterns were L/P elevations and surges in interstitial glutamine. Glutamine and pyruvate correlated with the cerebral perfusion pressure (r=0.25, r=0.24). Glutamine and the glutamine/glutamate ratio correlated with the intracranial pressure (r=-0.29, r=0.40). Glutamine surges appeared upon substantial lowering of the intracranial pressure by increased cerebrospinal fluid drainage. Increased interstitial glutamine and pyruvate levels may reflect augmented astrocytic glycolysis in recovering brain tissue with increased energy demand due to a high glutamate-glutamine turnover.</p>

O presente trabalho teve o objetivo de verificar a influência da inoculação de ingredientes intra ovo aos 18 dias de incubação de ovos oriundos de matrizes jovens e de pesos distintos. Ovos oriundos de matrizes com 30 semanas de idade foram separados em ovos leves e pesados, sendo incubados na mesma máquina incubadora. Aos 18 dias de incubação, no momento da transferência para o nascedouro, os ovos foram inoculados com soluções de Maltose, Polivitamínico, Zinco-Glicina, Glutamina, Mistura de todos os produtos descritos anteriormente e Cloreto de Sódio (controle). Como via de inoculação, as soluções foram utilizadas como diluentes da vacina de Marek efetuada intra-ovo aos 18 dias de incubação. Após o nascimento, 2460 pintinhos machos foram enviados para o aviário experimental onde foram divididos em 60 boxes em um delineamento inteiramente casualizado em esquema fatorial 2x6 (2 pesos e 6 soluções) totalizando 12 tratamentos com 5 repetições de 40 aves. Foram sacrificadas uma ave por repetição aos 00, 07 e 21 dias de idade para pesagem do saco da gema, intestino e fígado. Amostras de duodeno, jejuno e íleo foram enviadas para histologia para determinação de profundidade de criptas e altura de vilosidades. Amostras de sangue foram coletadas e enviadas para laboratório para determinação de nível de anticorpos contra reovírus e bronquite aviária. Os animais e a ração fornecida foram pesados semanalmente (07, 14, 21, 28, 35 e 42 dias) para determinação do peso, consumo e conversão alimentar. Aos 43 dias de idade 3 aves por repetição foram pesadas e sacrificadas para determinação do peso e rendimento de carcaça, peito com osso e pele e perna com osso e pele. Animais oriundos de ovos mais pesados obtiveram uma maior eclosão, peso ao nascimento e peso de fígado e intestino aos 00 dias. O peso aos 42 dias foi superior em aves oriundas de ovos pesados, produzindo uma carcaça e peito mais pesado, porém sem diferença de rendimento. Não houve diferença de conversão aos 42 dias de idade. Viabilidade de animais oriundos de ovos pesados foi superior de 00 a 07, 14 a 21 e 21 a 28 dias de idade, mas não afetou a viabilidade final. Peso do ovo não interferiu com o nível de anticorpos. As inoculações de soluções aos 18 dias de incubação obtiveram resultados variáveis dependendo do produto utilizado, tendo maior influência sobre altura de vilosidades e profundidade de criptas e sobre a produção de anticorpos. Não afetaram, entretanto, os parâmetros zootécnicos (ganho de peso, consumo de ração, conversão alimentar e viabilidade). A inoculação de produtos intra-ovo já é uma técnica possível de ser utilizada na avicultura industrial, entretanto, novos estudos devem ser ainda desenvolvidos no intuito de definir o melhor produto ou composto de produtos a ser utilizado / This trial had the objective to verify the influence of the in-ovo inoculation of ingredients at 18th day of incubation of eggs from different weights. Eggs from a broiler breeder flock with 30 weeks of age were separated in light and heavy eggs and were incubated in the same machine. At the 18th day of incubation, when the eggs were been transferred, they were inoculated with solutions of Maltose, Vitamins, Zinc-Glicine, Glutamine, mixture of all the ingredients and sodium chloride (control). The solutions were inoculated as Marek\'s vaccine diluter. After the eclosion, 2460 male chicks were send to the experimental house were they were divided on 60 boxes at a completely random design and a factorial 2x6 (two egg weigths and six solutions) design, summing 12 treatments with 5 repetitions of 40 chicks. One chick per repetition was sacrificed at 00, 07 and 21 days of age to weigth the yolk sac, intestine and liver. Samples of duodenum, jejunum and ileum were sent to histology to determinate villus high and cripts deep. Blood sample of the same birds were collected and sent to the laboratory to determinate anti body levels against reovirus and avian bronquitis. Animals and feed were weighted every week to determine the animal weight gain, feed consumption and feed conversion. At 43 days of age, 3 birds per repetition were weighted and sacrificed to determinate the carcass, breast and leg weight and yield. Animals from heavy eggs had a higher born weight, eclosion and liver and intestine weight at 00 days. At 42 days of age, birds from heavier eggs had a higher weight producing a heavier carcass and breast, but without yield variation. There was no difference on feed conversion at 42 days. Liveability of birds from heavier eggs were higher form 00 to 07, 14 to 21 and 21 to 28 days of age, but it didn\'t interfere the total livibility. Egg weight didn\'t interfere on the anti body level. The solutions inoculated at 18th day of incubation had variable results depending on the product utilized, influencing the villus height and cripts deep and anti body production. However, the solutions inoculation doesn\'t interfere on zoothecnical parameters as weight gain, feed consumption, feed conversion and livability. The in-ovo inoculation is a technique possible to be used on broiler production, however, new studies have to be done searching from the best product or ingredient to be used